Microscopic drug particles target Hard-to-Treat abdominal cancers in early trial

NCT ID NCT05159050

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tested a new way to deliver chemotherapy directly into the abdomen for people with advanced cancers that have spread to the lining of the belly. The treatment uses tiny particles loaded with paclitaxel, a standard chemo drug, to better target tumors. Only 4 people participated before the study ended, and the main goals were to check safety and find the best dose.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Iowa Hospitals & Clinics

    Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.